Popular Glaucoma News and Current Events

Popular Glaucoma News and Current Events, Glaucoma News Articles.
Sort By: Most Relevant | Most Recent
Page 1 of 15 | 583 Results
Eye conditions provide new lens screening for Alzheimer's disease
A study of 3,877 randomly selected patients found a significant link between three degenerative eye diseases -- age-related macular degeneration, diabetic retinopathy and glaucoma -- and Alzheimer' disease. (2018-08-08)

Birmingham research paves the way for new anti-fibrotic therapy for glaucoma
Researchers showed that novel low molecular weight dextran-sulphate, ILB®, can normalise matrix deposition inside the eye and lower IOP in a pre-clinical model of human glaucoma, paving the way for new anti-fibrotic therapies to be developed for the disease. (2021-01-07)

Grandmother, what bad eyes you have!
Senior citizens living in retirement homes often lack adequate ophthalmological care, according to a study by Luisa Thederan and co-authors published in the current issue of Deutsches Ärzteblatt International. Almost 21 percent of the surveyed residents were last seen by an ophthalmologist more than five years ago, while 39.9 percent were unable to provide any information about past ophthalmological examinations. (2016-05-31)

Air pollution linked to higher glaucoma risk
Living in a more polluted area is associated with a greater likelihood of having glaucoma, a debilitating eye condition that can cause blindness, finds a new UCL-led study in the UK. People in neighbourhoods with higher amounts of fine particulate matter pollution were at least 6% more likely to report having glaucoma than those in the least-polluted areas, according to the findings published in Investigative Ophthalmology & Visual Science. (2019-11-25)

Health burden of glaucoma has risen worldwide
The health burden of glaucoma has continuously increased around the globe in the past 25 years, according to an Acta Opthalmologica study. (2019-02-21)

Biomarkers facilitate early detection of glaucoma
Researchers at Ruhr-Universität Bochum have identified new potential biomarkers that may facilitate early detection of glaucoma in patients. Moreover, they ascertained that the mutation of a certain gene in mice causes intraocular pressure elevation. This, in turn, is one of the main risk factors for glaucoma. (2018-10-25)

Another reason to exercise: Protecting your sight
People who engage in moderate to vigorous physical activity may be able to significantly lower their risk of glaucoma, according to research presented today at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology. (2017-11-13)

New RNAi treatment targets eye inflammation
Scientists have developed a new RNA interference (RNAi) therapeutic agent that safely blocked ocular inflammation in mice, potentially making it a new treatment for human uveitis and diabetic retinopathy. (2017-02-13)

New directions found in understanding, fighting glaucoma
Two distinctive handfuls of short molecules that regulate gene expression have been found in the eye fluid of patients with two distinct types of vision degenerating glaucoma. (2018-02-26)

Toward precision medicine: First comprehensive look at human retinal cell diversity
In work that brings researchers closer to the goal of precision medicine approaches to treating glaucoma and other neurodegenerative vision diseases, a new IUPUI study has, for the first time, been able to identify a wide variety of previously unknown cell subtypes in the human eye. (2018-03-22)

Study advances gene therapy for glaucoma
In a study published today in the scientific journal Investigative Ophthalmology and Visual Science, Kaufman and Curtis Brandt, a fellow professor of ophthalmology and visual sciences at UW-Madison, showed an improved tactic for delivering new genes into the eye's fluid drain, called the trabecular meshwork. It could lead to a treatment for glaucoma. (2018-01-16)

University of Iowa researchers use CRISPR engineering to prevent certain glaucoma in mice
A University of Iowa-led team of researchers has used the gene editing method called CRISPR-Cas9 to disrupt a mutant gene that is responsible for some forms of glaucoma, one of the most common causes of irreversible blindness. (2017-10-02)

Nerve growth factor: Early studies and recent clinical trials
NGF is the first discovered member of a family of neurotrophic factors, collectively indicated as neurotrophins, (which include brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin 4/5). NGF was discovered for its action on the survival and differentiation of selected populations of peripheral neurons. (2019-01-18)

Study finds genetic link between thinner corneas and increased risk of glaucoma
Genetic studies in mice point to a protein called POU6F2, which can modulate corneal thickness, as a possible risk factor for glaucoma in humans, report Eldon Geisert of Emory University, and colleagues, Jan. 25 in PLOS Genetics. (2018-01-25)

World's largest clinical specialty database yields critical insights
The American Academy of Ophthalmology today announced key milestones and clinical insights from studies powered by its clinical database. The IRIS® Registry (Intelligent Research In Sight) has amassed more than 41.2 million unique patients in its database, representing 166.2 million patient visits, covering 11 percent of the US population. (2017-11-13)

Changes of the cell environment are associated with certain eye diseases
In case of ischemic injury to the retina, changes occur in the protein scaffold in the environment of retinal cells, the so-called extracellular matrix. Various eye diseases, such as glaucoma, are associated with such ischemic events. Researchers at Ruhr-Universität Bochum describe how the extracellular matrix is affected by these processes in the journal Scientific Reports. (2017-03-15)

Cost of glaucoma medications may impact treatment
In the US, management of glaucoma costs about $2.5 billion per year. Of the $1.9 billion in direct costs, glaucoma medications account for an estimated 38 percent to 52 percent of the total. In an article published in the January 2008 issue of the American Journal of Ophthalmology, researchers from Texas A&M University analyzed the economics of medically managing glaucoma. The yearly costs to patients of various topical glaucoma medications were calculated and significant price differences and increases in cost over time were found. (2007-12-28)

Avoiding medications that promote weight gain when managing obesity
While diet, exercise and behavior modification are essential components of obesity management, a successful long-term weight loss strategy should also include avoiding or minimizing medication-related weight gain, according to a new report from Weill Cornell Medicine. (2017-02-13)

Most shoppers unaware of major risk factor for most common form of glaucoma in UK
New study suggests that less than a fifth of shoppers were aware of the need for tests of the pressure inside their eyes (intraocular pressure), when measured at a Pop-Up health check station set up across eight shopping centers in England. The study also found that when the eye pressure test was advertised alongside a blood pressure test, significantly more shoppers took up the opportunity to answer questions and get tested for both. (2019-11-27)

Meditation: An effective new therapy to reduce eye pressure in primary open-angle glaucoma
A new era in the management of glaucoma is ushered in by a landmark study published in the Journal of Glaucoma, Official Journal of the World Glaucoma Association. Patients with primary open angle glaucoma (POAG) showed significant improvements of both ocular and general health after participating in a program of mindful meditation focused on breathing compared to the control group that did not partake. (2018-11-05)

New glaucoma treatment could ease symptoms while you sleep
Eye drops developed by UBC researchers could one day treat glaucoma while you sleep -- helping to heal a condition that is one of the leading causes of blindness around the world. (2018-04-11)

New diagnostic technique picks up the S in vision
A new technique that could help improve diagnosis of vision disorders has been successfully tested at the University of Bradford, UK. (2018-05-01)

Therapy applied directly inside the eye best for treating uveitic macular edema
Delivery of corticosteroids directly into the eye is more effective than injections adjacent to the eye, according to results from a comparative clinical trial of macular edema in patients with noninfectious uveitis. (2018-09-27)

Half of vision impairment in first world is preventable
Around half of vision impairment in Western Europe is preventable, according to a new study published in the British Journal of Ophthalmology. (2018-03-26)

Altitude sickness drug appears to slow progression of glioblastoma
A drug used to treat altitude sickness may help patients with glioblastoma, according to a study published July 4, 2018, in the journal Science Translational Medicine. (2018-07-09)

Experimental drug, implanted in eye, could fight glaucoma
An experimental drug, consisting of cells manufactured and implanted in the eye to stimulate optic nerve growth and activity, could be an entirely new way of fighting glaucoma, according to BrightFocus Foundation. (2016-10-14)

Keto diet protects optic nerve in glaucoma mouse model
Switching mice destined to develop glaucoma to a low carbohydrate, high fat diet protects the cells of the retina and their connections to the brain from degeneration, according to research published in JNeurosci. The study adds to others that have found this type of diet to have neuroprotective effects in conditions such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). (2018-05-14)

USC study finds blindness and visual impairment will double by 2050
Visual impairment and blindness prevalence in the US to double by 2050 according to study by USC Roski Eye Institute researchers. Key study findings include: growing population of aging baby boomers leads to increase in vision loss and blindness in the US; women and minority populations, especially Latinos, carry the largest burden; and Mississippi, Louisiana will top list for blindness; Florida, Hawaii will lead visual impairment. (2016-05-19)

A closer look at the eye
URMC researchers have developed a new imaging technique that allowed the first glimpse of individual cells in the retina, a layer of tissue at the back of the eye. The new technique could allow earlier diagnosis and treatment for diseases like glaucoma and prevent vision loss caused by death of these retinal cells. (2017-01-02)

Most glaucoma patients don't ask about medication costs
Less than one-third of patients with glaucoma talk to their doctor about the costs of medications needed to control their disease, reports a study in the December issue of Optometry and Vision Science, the official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer. (2017-12-01)

NTU Singapore scientists develop 'contact lens' patch to treat eye diseases
NTU Singapore scientists have developed a 'contact lens' patch with microneedles that could be a painless and efficient alternative to current methods of treating eye diseases such as glaucoma. Patients are unable to keep up with the prescribed regime of current localised treatment methods like eye drops, which are hindered by the eye's natural defences, blinking and tears. Eye injections can be painful and carry an infection risk and eye damage. (2018-11-20)

Artificial intelligence detects diabetic retinopathy and related eye diseases among patients
A computing system with artificial intelligence that can learn to do tasks that normally require human intelligence could detect retinal images that did and did not show diabetic retinopathy and related eye diseases in multiethnic populations. (2017-12-12)

Do racial and gender disparities exist in newer glaucoma treatments?
The American Glaucoma Society today announced that it has awarded a grant to Mildred MG Olivier, MD, to study how often minimally invasive glaucoma surgery (MIGS) devices and procedures are used in black and Latino glaucoma patients and whether these devices perform similarly across races, ethnicities, genders, ages, and regions. The goal of Dr. Olivier's research is to increase quality care for glaucoma patients in all demographic groups. (2018-03-02)

Cutting-edge findings in cannabis research
The authors have studied cannabis therapies for many years at international research centers, examining its effects, potential applications, and risks. The trials have demonstrated that cannabis have analgesic effects and could be used for treating patients suffering from chronic pain. (2016-05-23)

Neutron study of glaucoma drugs offers clues about enzyme targets for aggressive cancers
A team of researchers from ORNL's Energy and Transportation Science Division is using neutron imaging to study particulate filters that collect harmful emissions in vehicles. A better understanding of how heat treatments and oxidation methods can remove layers of soot and ash from these filters could lead to improved fuel-efficiency. (2018-02-12)

New study: Leading cause of blindness could be prevented or delayed
In a major scientific breakthrough, a drug used to treat Parkinson's and related diseases may be able to delay or prevent macular degeneration, the most common form of blindness among older Americans. The study, published in the American Journal of Medicine, was funded in part by BrightFocus Foundation. (2015-11-09)

Nanosponges show promise for potentially blinding eye infections
In a new study, researchers demonstrate using a mouse model that engineered nanosponges can be used to protect eyes from infections caused by Enterococcus faecalis. Enterococcus faecalis contain a toxin called cytolysin, which is found in roughly 50 percent of isolates that cause post-operative intraocular infections seen in the United States. (2017-11-22)

New glaucoma drugs yield large, lasting reductions in intraocular pressure
Two novel ocular hypotensive agents that have just been approved for use in humans -- netarsudil and latanoprostene bunod (LBN) -- greatly reduce intraocular pressure, with lasting results in various animal models of glaucoma and in humans. (2018-02-21)

Monitoring glaucoma at home
Glaucoma is a chronic condition that affects cells at the back of the eye. It is the leading cause of irreversible blindness worldwide. People with glaucoma, or at risk of developing glaucoma, require lifelong monitoring, including regular eye tests to track the progression of the disease. A study from City, University of London is the first in the world that suggests glaucoma eye tests can be performed accurately at home by patients themselves. (2020-11-20)

UHN vision scientists discover potential neuroprotective treatment for glaucoma
A research team led by scientists at the Krembil Research Institute in Toronto has identified a new neuroprotective factor that has the potential to help people suffering from the common blinding disease glaucoma. (2017-11-06)

Page 1 of 15 | 583 Results
   First   Previous   Next      Last   
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.